Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy
We read with great interest the study by Su et al. reporting clinical and immunologic outcomes of patients with primary membranous nephropathy treated with obinutuzumab.
Authors
- Erhan Eröz (ORCID: https://orcid.org/0000-0003-1044-1013)
- Cihan Heybeli
- İlker Atay (ORCID: https://orcid.org/0009-0004-4558-2152)
Institutions
- Dokuz Eylül University (TR)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1016/j.ekir.2026.103774
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 34.94